Elias Caro, executive vice president of international diagnostics and global life sciences commercial operations at Beckman Coulter, has retired effective July 31, according to an 8-K filing with the US Securities and Exchange Commission. Caro will receive biweekly payments of $12,516.67 for a 17-month period that began Aug. 1, a prorated bonus for 2006 at target plus a lump sum payment of 10 percent of the bonus to reflect retirement plan contributions that would have been made had he continued to be employed, according to the filing.
Deltadot appointed Andrew Carr as chairman of its board this week.
Previously, Carr was a director of Amersham and CEO of Amersham Biosciences. He has been executive chairman and is now the non-executive chairman of Akubio.
He received his PhD in zoology from the